Hydralazine Hydrochloride Tablet
Product Images NDC 71335-2352

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Hydralazine Hydrochloride (NDC 71335-2352). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chem Structure (Image 01)

FDA Label Image

Label (Lbl713352352)

Label (Lbl713352352)
The text provides information about a medication in tablet form containing 25 mg of Hydralazine Hydrochloride, USP. It includes instructions on storage conditions (20° to 25°C) and dispensing in a child-resistant container. The medication is manufactured by Bryant Ranch Prepack, Inc. and ScieGen Pharmaceuticals, Inc.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.